EligibilityCriteriaEthicsCommitteePilotStudyPatientRecruitmentFollow-up VisitOpen-LabelTrialParallelStudyControlGroupDouble-BlindStudyInstitutionalReviewBoard(IRB)GoodClinicalPractice(GCP)SafetyProfileData SafetyMonitoringBoard(DSMB)DropoutRateClinicalResearchCoordinatorProtocolDeviationSourceDataVerificationInvestigatorMeetingPrincipalInvestigatorPlaceboAdaptiveDesignRandomizationStandardOperatingProcedure(SOP)AdverseEventInterventionSurrogateEndpointPhaseIClinicalEndpointBlindingStatisticalAnalysisPlan(SAP)SponsorRecruitmentTargetScreeningVisitEfficacyTrialMonitorDataManagementMulticenterTrialTrialRegistryProtocolInformedConsentPhaseIICaseReportForm(CRF)RegulatoryAuthorityClinicalStudyReport(CSR)PhaseIIIPhaseIVDataLockEndpointCrossoverStudyAuditTrailEligibilityCriteriaEthicsCommitteePilotStudyPatientRecruitmentFollow-up VisitOpen-LabelTrialParallelStudyControlGroupDouble-BlindStudyInstitutionalReviewBoard(IRB)GoodClinicalPractice(GCP)SafetyProfileData SafetyMonitoringBoard(DSMB)DropoutRateClinicalResearchCoordinatorProtocolDeviationSourceDataVerificationInvestigatorMeetingPrincipalInvestigatorPlaceboAdaptiveDesignRandomizationStandardOperatingProcedure(SOP)AdverseEventInterventionSurrogateEndpointPhaseIClinicalEndpointBlindingStatisticalAnalysisPlan(SAP)SponsorRecruitmentTargetScreeningVisitEfficacyTrialMonitorDataManagementMulticenterTrialTrialRegistryProtocolInformedConsentPhaseIICaseReportForm(CRF)RegulatoryAuthorityClinicalStudyReport(CSR)PhaseIIIPhaseIVDataLockEndpointCrossoverStudyAuditTrail

Clinical Trials Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
  1. Eligibility Criteria
  2. Ethics Committee
  3. Pilot Study
  4. Patient Recruitment
  5. Follow-up Visit
  6. Open-Label Trial
  7. Parallel Study
  8. Control Group
  9. Double-Blind Study
  10. Institutional Review Board (IRB)
  11. Good Clinical Practice (GCP)
  12. Safety Profile
  13. Data Safety Monitoring Board (DSMB)
  14. Dropout Rate
  15. Clinical Research Coordinator
  16. Protocol Deviation
  17. Source Data Verification
  18. Investigator Meeting
  19. Principal Investigator
  20. Placebo
  21. Adaptive Design
  22. Randomization
  23. Standard Operating Procedure (SOP)
  24. Adverse Event
  25. Intervention
  26. Surrogate Endpoint
  27. Phase I
  28. Clinical Endpoint
  29. Blinding
  30. Statistical Analysis Plan (SAP)
  31. Sponsor
  32. Recruitment Target
  33. Screening Visit
  34. Efficacy
  35. Trial Monitor
  36. Data Management
  37. Multicenter Trial
  38. Trial Registry
  39. Protocol
  40. Informed Consent
  41. Phase II
  42. Case Report Form (CRF)
  43. Regulatory Authority
  44. Clinical Study Report (CSR)
  45. Phase III
  46. Phase IV
  47. Data Lock
  48. Endpoint
  49. Crossover Study
  50. Audit Trail